Minimal sex-differential modulation of reactivity to pathogens and toll-like receptor ligands following infant Bacillus Calmette–Guérin Russia vaccination
Bacillus Calmette–Guérin (BCG), the only licensed vaccine against tuberculosis, has been shown to provide heterologous protection against unrelated pathogens and enhance antibody responses to several routine expanded program on immunization (EPI) vaccines. Understanding these heterologous effects is...
Κύριοι συγγραφείς: | Darboe, F, Adetifa, JU, Reynolds, J, Hossin, S, Plebanski, M, Netea, MG, Rowland-Jones, SL, Sutherland, JS, Flanagan, KL |
---|---|
Μορφή: | Journal article |
Έκδοση: |
Frontiers Media
2017
|
Παρόμοια τεκμήρια
-
Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette–Guérin Russia Vaccination
ανά: Fatoumatta Darboe, κ.ά.
Έκδοση: (2017-09-01) -
Reiter's syndrome postintravesical Bacillus Calmette–Guérin instillations
ανά: Ng, K.L., κ.ά.
Έκδοση: (2017) -
Bacillus Calmette–Guérin Immunotherapy for Cancer
ανά: Fabíola Cardillo, κ.ά.
Έκδοση: (2021-05-01) -
Bacillus Calmette–Guérin and Bladder Cancer
ανά: Azad H.A. Razack
Έκδοση: (2007-10-01) -
Hepatitis in Disseminated Bacillus Calmette-Guérin Infection
ανά: Markus U Göttke, κ.ά.
Έκδοση: (2000-01-01)